News

Americans are ready and willing to leverage health apps and wearable devices to improve their personal health, according to the findings released from the fifth annual Makovsky/Kelton "Pulse of Online Health" Survey.

Home February 24, 2015
Home
News

Medtronic announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a transitional pass-through payment for the company’s IN.PACT Admiral drug-coated balloon (DCB) under the Medicare hospital outpatient prospective payment system (OPPS). The decision removes a potential barrier to patient access to this new medical device, which represents an improvement to the standard of care for peripheral arterial disease in the upper leg.

Home February 23, 2015
Home
News

C. R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a pass-through payment for the Lutonix drug-coated balloon (DCB) under the Medicare hospital outpatient prospective payment system. This approval follows a unanimous favorable recommendation from the U.S. Food and Drug Administration’s (FDA) Circulatory Systems Devices Advisory Panel.

Home February 23, 2015
Home
Technology

Pie Medical Imaging BV announced that it received 510(k) clearance from the U.S. Food and Drug Administration for its CAAS A-Valve product including the quantitative Regurgitation Analysis (qRA) workflow. The qRA workflow is the first 510(k) cleared image analysis technology to determine aortic regurgitation based on X-ray angiography.

Home February 23, 2015
Home
Medtronic's Attain Performa Quadripolar Lead and VivaQuad XT CRT-D system. Quadripolar leads enable more programming options to enable better patient care with this implantable cardioverter defibillator (ICD)..
Feature | Implantable Cardioverter Defibrillator (ICD) | Dave Fornell

There have been several recent advancements in implantable cardioverter defibrillator (ICD) technology to extend battery life, improvements in patient monitoring to avoid needless shocks, the introduction of quadripolar lead devices to improve device programming and to improve therapy effectiveness, and development of MRI-safe ICDs.

Home February 23, 2015
Home
Technology

Agfa Healthcare announced the commercial launch of its Enterprise Imaging for Cardiology Suite and strategic relationship with TomTec to provide a unified cardiology diagnostic and clinical imaging solution. The solution will be on display at the American College of Cardiology (ACC) 2015 meeting, March 14-16, 2015 in San Diego.

Home February 23, 2015
Home
Medtronic, Reveal Linq ICM, atrial fibrillation, AF, study, remote monitoring
Feature

Medtronic announced the results of a new "real-world" study of patients who have had a cryptogenic stroke, in which the Reveal Linq Insertable Cardiac Monitor (ICM) detected atrial fibrillation (AF) in everyday practice at an even greater rate than that found in a recent clinical trial (the CRYSTAL AF Study, which was published in The New England Journal of Medicine).

Home February 20, 2015
Home
News

A recently completed National Institutes of Health-funded trial confirms the efficacy of blood flow measurement technology from VasSol Inc. to predict the possibility of repeated stroke in at-risk individuals.

Home February 20, 2015
Home
News

Pediatric cardiology researchers and clinicians from numerous centers around the world gathered at the Cardiology 2015: the 18th Annual Update on Pediatric and Congenital Cardiovascular Disease conference, Feb. 11-15 in Scottsdale, Ariz. sponsored by The Children’s Hospital of Philadelphia and Phoenix Children’s Hospital.

Home February 20, 2015
Home
News

At the 2015 annual meeting of the Healthcare Information and Management Systems Society (HIMSS), Carestream will demostrate its flexible Clinical Collaboration Platform, which now offers a new module to tag clinical data files and bring them into the workflow. These new capabilities build upon Carestream’s fully featured vendor neutral archive (VNA) architecture.

Home February 20, 2015
Home
Discovery MR750, MRI recall, GE, FDA recall
Feature | Dave Fornell

GE Healthcare initiated a voluntary field corrective action for all of its magnetic resonance imaging (MRI) systems with superconducting magnets that were manufactured from 1985 through today. The U.S. Food and Drug Administration (FDA) classified it as a Class 1 product recall Feb. 18.

Home February 20, 2015
Home
News

Biotronik announced the completion of enrollment in the BIOSOLVE-II trial — a clinical study investigating the safety and performance of DREAMS (DRug Eluting Absorbable Metal Scaffold).

Home February 19, 2015
Home
News

Three out of five healthcare IT professionals believe that government mandates are having a negative effect on their industry, according to a study conducted by Peak 10, a national information technology (IT) infrastructure and cloud services provider. The majority (94 percent) also noted that complying with regulations influences IT strategy and decision-making. With rare exception, respondents claimed they lack the expertise necessary to navigate the maze of government regulations.

Home February 19, 2015
Home
Lutonix, drug eluting balloon, drug coated balloon
Feature | Drug-Eluting Balloons | Dave Fornell

Drug-eluting balloons (DEBs) have been one of the long-awaited new transcatheter technologies to help reduce high restenosis rates in peripheral artery disease (PAD). The U.S. Food and Drug Administration (FDA) cleared C. R. Bard’s Lutonix 035 DEB in November 2014 and Medtronic’s In.Pact Admiral DEB in January 2015. Both are indicated for use in the superficial femoral and popliteal arteries in the upper leg.

Home February 19, 2015
Home
News

At the SPIE Medical Imaging Conference, ContextVision exhibited results from research conducted in collaboration with Texas Instruments and High Performance Consulting on 3-D adaptive filtering for improved image quality on portable medical devices. Björn Norell, research scientist at ContextVision, presented the findings.

Home February 19, 2015
Home
Subscribe Now